Market Place
Sourcing Support
Mabion, NovalGen Partner to Bring NVG-222 to Market
30 Jun 2025 //
CONTRACTPHARMA
Mabion Launches €500,000 Oncology Services Contest
18 Jun 2025 //
CONTRACTPHARMA
Mabion Releases First NVG-222 Batch for Human Trials
17 Jun 2025 //
PRESS RELEASE
Mabion & WPD Pharma Collaborate on WPD-401 Analytical Methods
18 Apr 2025 //
PRESS RELEASE
Sartorius & Mabion Partner to Boost Biopharma Development
14 Apr 2025 //
PRESS RELEASE
Mabion to fulfill CDMO orders for a new client – IBMP
14 Apr 2025 //
PRESS RELEASE
Mabion Wins PLN 5.5M CDMO Orders From UK-Based New Client
16 Aug 2024 //
PRESS RELEASE
Mabion Reports Solid Q1 2024 Results And Growing Bid Pipeline
14 May 2024 //
PRESS RELEASE
Very good results and successful implementation of Mabio Strategy in 2023
16 Apr 2024 //
PRESS RELEASE
Nigel Stapleton Becomes Mabion`s Business Development Director For Europe
15 Apr 2024 //
PRESS RELEASE
Marty Henehan Joins Mabion As VP Business Development For North America
20 Feb 2024 //
PRESS RELEASE
Mabion presents ESG Strategy for 2024-2027
12 Feb 2024 //
PRESS RELEASE
Mabion Announces Commercial Manufacturing Agreement for Novavax COVID-19 Vaccine
08 Oct 2021 //
PRESS RELEASE
Mabion Announces Agreement with Novavax for Large-Scale Vaccine
03 Mar 2021 //
MABION
Mylan Boasts of 16 Biosimilars in Portfolio After Mabion Rituximab Deal
12 Nov 2016 //
BIOPHARMA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.